Grant: Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
University of Manitoba
$300,000.00
Continuous Neuroprotection Based Personalized Depth of Sedation Targeting in Biomechanical Neural Injury
FY 2024-25
Summary
Recent data show that current interventions in the critical care management of traumatic brain injury (TBI) patients fail to correct dysfunctional cerebral autoregulation (CA). Acute phase treatment of critically ill TBI patients consists of reducing the intra-cranial pressure (ICP), employing various therapies, including high levels of sedation. High dose sedatives have been linked with worse neurologic outcomes in the general intensive care unit (ICU) population, with burst suppression showing deterioration in CA. Our ability to titrate these sedative agents is commonly limited to clinical examination, with high patient-to-patient heterogeneity and poor temporal resolution. Electroencephalogram (EEG) based bispectral index (BIS) is a method that has been commonly employed in anesthesia to confirm depth of sedation for surgical procedures, with sedation titration to target BIS values. Recent pilot work from our group has evaluated the link between objective depth of sedation (measured by BIS) and continuously measured CA, showing a novel patient-specific depth of sedation associated with CA (BISopt), where CA is the least deranged. This suggests that both low and high levels of sedation are linked with worse CA in TBI and non-TBI populations, with preliminary evidence showing independence from drug type and other physiologic metrics (ICP, arterial blood pressure (ABP) and optimal cerebral perfusion pressure (CPPopt). It is possible that poor cognitive outcomes related to sedation in critical illness are a function of secondary insult exposure from impaired CA. However, previous BISopt work required artifact clean signal sources through cumbersome manual methods prior to derivation, and only described the metric as an "after the fact" phenomenon (requiring physiologic data from the entire ICU stay to derive), leaving critical technologic knowledge gaps. This study aims to create novel BIS artifact detection and continuous BISopt derivation pipelines.
Department
Program
Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
512581
Name
Zeiler Frederick A
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Catalyst Grant: Development and validation of new biomedical techniques and technologies
Projecttitle
Continuous Neuroprotection Based Personalized Depth of Sedation Targeting in Biomechanical Neural Injury
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
Keyworddelim
Artifact Detection Algorithms; Big Data; Biomedical Engineering; Cerebral Physiology; Mathematical Models Of Biologic Processes; Neural Injury; Neuroprotection; Personalized Physiologic Targets; Tbi; Time-Series Models
Abstract
Recent data show that current interventions in the critical care management of traumatic brain injury (TBI) patients fail to correct dysfunctional cerebral autoregulation (CA). Acute phase treatment of critically ill TBI patients consists of reducing the intra-cranial pressure (ICP), employing various therapies, including high levels of sedation. High dose sedatives have been linked with worse neurologic outcomes in the general intensive care unit (ICU) population, with burst suppression showing deterioration in CA. Our ability to titrate these sedative agents is commonly limited to clinical examination, with high patient-to-patient heterogeneity and poor temporal resolution. Electroencephalogram (EEG) based bispectral index (BIS) is a method that has been commonly employed in anesthesia to confirm depth of sedation for surgical procedures, with sedation titration to target BIS values. Recent pilot work from our group has evaluated the link between objective depth of sedation (measured by BIS) and continuously measured CA, showing a novel patient-specific depth of sedation associated with CA (BISopt), where CA is the least deranged. This suggests that both low and high levels of sedation are linked with worse CA in TBI and non-TBI populations, with preliminary evidence showing independence from drug type and other physiologic metrics (ICP, arterial blood pressure (ABP) and optimal cerebral perfusion pressure (CPPopt). It is possible that poor cognitive outcomes related to sedation in critical illness are a function of secondary insult exposure from impaired CA. However, previous BISopt work required artifact clean signal sources through cumbersome manual methods prior to derivation, and only described the metric as an "after the fact" phenomenon (requiring physiologic data from the entire ICU stay to derive), leaving critical technologic knowledge gaps. This study aims to create novel BIS artifact detection and continuous BISopt derivation pipelines.
Competitiondate
202407
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Zeiler, Frederick A; Mendelson, Asher A
Approvedterm
2 ans 0 mois
Cihrcontribution2
INMHA~ $300,000~ $0~